Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, November 12, 2012
Stuart Needleman, President and Chief Operating Officer, Aptuit LLC, announced that the number of clients placing work at The Aptuit Center for Drug Discovery & Development in Verona, Italy has reached 100, giving the site a strong vote of confidence...
read more
Friday, February 22, 2013
Stuart Needleman, President and Chief Operating Officer, Aptuit LLC, announced that the company has formed the Aptuit Scientific Advisory Board (SAB) comprised of scientific experts from within the company. The SAB will regularly meet to assess ...
read more
Thursday, October 31, 2013
Quality by Design (QbD) and its systematic approach to development begins with a predefined objective and emphasizes sound science and quality risk principles as an integral part of product development and process control implementation, and can help...
read more
Anixa Biosciences has established a strategic alliance and license agreement with Cleveland Clinic for breast cancer vaccine technology.
read more
Thursday, November 07, 2019
ANI Pharmaceuticals announced its partner Pii has received FDA approval of a Prior Approval Supplement for Bretylium Tosylate Injection.
read more
Thursday, December 18, 2014
Anavex Life Sciences Corp. (“Anavex” or the “Company”) (OTCQX: AVXL), a clinical-stage biopharmaceutical company developing novel drug candidates to treat Alzheimer’s disease, other diseases of the central nervous system (CNS) and various types of ...
read more
Monday, February 09, 2015
Anavex Life Sciences Corp. (“Anavex” or the “Company”) (OTCQX: AVXL) today announced that Christopher U. Missling, PhD, President and Chief Executive Officer, will present at the 17th Annual BIO CEO & Investor Conference on Tuesday, February 10, 2015...
read more
ANA and Quotient Sciences announced a partnership to support the manufacturing of ANA001 as a potential treatment for COVID-19.
read more
SSCI announced the availability of in vitro bioequivalence testing services.
read more
AMRI (NASDAQ: AMRI) today announced that it has signed a definitive agreement to acquire all of the outstanding membership interests of Oso Biopharmaceuticals Manufacturing, LLC (“OsoBio”) for $110 million in cash. OsoBio is recognized as a premier ...
read more
Wednesday, January 09, 2013
AMRI announced today that Richard A. Saffee has been promoted to the newly created role of Vice President and General Manager of Large Scale Manufacturing, effective immediately. He will continue to report to Steven R. Hagen, Ph.D., Senior Vice ...
read more
Wednesday, January 10, 2018
AMRI announced Michael Mulhern has joined the company as chief executive officer, succeeding William S. Marth.
read more
AMRI has been named as the exclusive supplier of the API in Cassiopea SpA’s recently approved acne treatment, Winlevi cream 1%.
read more
AMRI will now offer its impurity solutions as a stand-alone service.
read more
AMRI (NASDAQ: AMRI) announced today that its subsidiary, India Pvt. Ltd. has been recognized by Abbott Health Care Pvt. Ltd. for the reliable supply of generic medications for the period from April 2011 to March 2012. This is the second year in a row...
read more